Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est
Benzinga Newsdesk 4 days ago
NewsGuidance
Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.362 billion-$2.447 billion to $2.395 billion-$2.441
Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.362 billion-$2.447 billion to $2.395 billion-$2.441 billion vs $2.406 billion estimate.